Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Triple-dummy, National, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Leningrado Association in the Treatment of Hypertension
The purpose of this study is to evaluate the efficacy and safety of Leningrado association on the treatment of hypertension.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
April 1, 2022
Primary Completion Date
November 1, 2023
Completion Date
January 1, 2024
Last Updated
July 27, 2022
LENINGRADO association
DRUG
Indapamide SR 1.5 MG
DRUG
Levamlodipine 2.5/ 5 mg
DRUG
Leningrado association Placebo
OTHER
Indapamide SR Placebo
OTHER
Levamlodipine placebo
OTHER
Lead Sponsor
EMS
NCT07218029
NCT06649110
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06481852